Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

CNS 7Genitourinary 3Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Breast 1

Conditions

Kidney Neoplasms 2Urinary Bladder Neoplasms 1Postoperative Complications 1Hemorrhage 1Carcinoma, Renal Cell 1

Interventions

Docetaxel 390pembrolizumab 325Prednisone 284Gemcitabine 273enzalutamide 254Radiotherapy 251Nivolumab 247Magnetic Resonance Spectroscopy 247Cisplatin 209Abiraterone Acetate 197Radiosurgery 184Leuprolide 182Sunitinib 169Carboplatin 161bicalutamide 148Goserelin 145Androgen Antagonists 142Specimen Handling 138Ipilimumab 128Paclitaxel 125Cyclophosphamide 116acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 110Bevacizumab 109Everolimus 107apalutamide 98cabozantinib 97abiraterone 97Sorafenib 97atezolizumab 96Radiation 89

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Mannitol × Genitourinary × Clear all
NCT02924922 2020-09-01

Assessment of Oncological and Functional Outcomes After Robot Assisted Partial Nephrectomy Versus Laparoscopic Partial Nephrectomy

Luzerner Kantonsspital

Phase NA Completed
85 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT01606787 2018-10-15

Mannitol Use During Partial Nephrectomy Prior to Renal Ischemia and Impact on Renal Function Outcomes

Memorial Sloan Kettering Cancer Center

Phase 3 Completed
210 enrolled 9 charts
Genitourinary

Kidney Neoplasms

NCT02373735 2015-12-30

Effect of SVV Guided Fluid Therapy on Blood Loss and Postoperative Outcomes

Asan Medical Center

Phase NA Completed
64 enrolled
Genitourinary

Urinary Bladder Neoplasms, Hemorrhage, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡